What the published literature examines.
For each compound, the papers indexed on PubMed that discuss it — journal, year and PMID, as the record holds them. A library for checking what has been studied, and nothing more than that.
- Papers
- 202
- Compounds
- 30
- Published
- 1967–2026
- Journals
- 145
30 compounds · 202 papers
Tissue
5 compoundsCognitive
4 compoundsMetabolic
4 compoundsHormone
8 compoundsSleep
2 compoundsImmune
2 compoundsSkin
1 compoundLongevity
4 compoundsHow the lists are built.
The same four steps for every compound, run in code so the rule can be read rather than taken on trust.
- A PubMed search per compound, by its scientific name where the catalogue uses a coded one. Clinical trials, randomised controlled trials and case reports are excluded in the search itself.
- A title screen. Any title that reads as a clinical claim, describes use in people, or names a medical condition is dropped. Where fewer papers survive, the list is shorter; the screen is never loosened to fill it.
- Up to eight kept, in PubMed’s relevance order. A compound left with fewer than 3 has no page here — its papers stay on its product page.
- One list per compound. A nasal spray shares its compound’s list and is named on that page.
Titles, journals and author names are third-party text, reproduced as indexed. There are no abstracts here and no summaries of findings. The other 15 products in the catalogue — supplies, blends, bundles, and compounds with fewer than 3 indexed papers — have no page in the library.
A reference list, not evidence. Inclusion means a paper discusses the compound — not that it supports any use, and not that it describes this product.
For laboratory and research use only · Not for human or veterinary consumption · Not evaluated by the FDA